Stopping opioids can trigger intense withdrawal symptoms that make it extremely difficult to remain opioid-free. Lucemyra is a prescription medication that can lessen some of those physical symptoms.
However, Lucemyra is not a comprehensive opioid detox program. It does not eliminate withdrawal, treat opioid use disorder on its own, or protect someone from relapse. Understanding what Lucemyra can and cannot do can help people make more informed decisions about treatment for opioid withdrawal.
What Is Lucemyra & Lofexidine?
Lucemyra is the brand name for lofexidine, a non-opioid prescription medication used to reduce opioid withdrawal symptoms in adults who abruptly stop taking opioids. Generic lofexidine tablets are also available. The U.S. Food and Drug Administration (FDA) approved lofexidine for this use in 2018.Lofexidine belongs to a class of medications called central alpha-2 adrenergic agonists. It is not an opioid, does not produce an opioid high, and is not a federally controlled substance.
How Does Lucemyra (Lofexidine) Work?
When a person who is physically dependent on opioids stops taking them, the nervous system can become overactive. This causes a surge of norepinephrine, a chemical involved in the body’s stress response. The result can be sweating, chills, a pounding heart, muscle tension, stomach cramps, restlessness, and other symptoms associated with opioid withdrawal. Also called noradrenaline, it drives your body’s fight-or-flight response.Lofexidine reduces norepinephrine release and lowers nervous system overactivity. It may help ease symptoms such as:
- General feelings of sickness
- Aches and pains
- Chills or feeling cold
- Stomach cramps
- Muscle tension, spasms, or twitching
- Pounding heartbeat
- Yawning
- Runny or watery eyes
- Difficulty sleeping
What Lucemyra Does Not Do
Lucemyra has a specific role in withdrawal management. It is important not to confuse symptom relief with comprehensive treatment for Opioid Use Disorder (OUD).Lucemyra does not:
- Bind to or block opioid receptors
- Reverse an opioid overdose
- Completely stop or override opioid withdrawal
- Treat opioid use disorder by itself
- Prevent someone from returning to opioid use
- Restore opioid tolerance after detox
- Remove opioids from the body
How Long Is Lucemyra Taken?
Lucemyra is intended for short-term use during acute opioid withdrawal. According to its prescribing information, treatment may continue for up to 14 days, with dosing based on symptoms and side effects. Peak withdrawal symptoms often occur during the first five to seven days after the last use of an opioid. However, the timeline varies depending on the person’s opioid use, dose, and length of use.Lucemyra should be taken only as prescribed. The dose may need to be adjusted for people with kidney or liver impairment or for those who experience side effects.
It should also be tapered rather than stopped suddenly. Abruptly discontinuing Lucemyra can cause a sharp increase in blood pressure and symptoms including anxiety, insomnia, chills, sweating, diarrhea, and limb pain.
What Are the Side Effects of Lucemyra?
The most common Lucemyra side effects include:- Low blood pressure
- A slow heart rate
- Dizziness or lightheadedness
- Sleepiness or sedation
- Dry mouth
- A drop in blood pressure when standing up
People taking Lucemyra should avoid dehydration and overheating, avoid driving or operating machinery until they know how the medication affects them, and stand up slowly.
Lucemyra Drug Interactions & Safety Concerns
Before taking Lucemyra, patients should tell their healthcare provider about every prescription medication, over-the-counter drug, supplement, and substance they use.- Alcohol, benzodiazepines, barbiturates, and other sedating drugs
- Combining these substances with Lucemyra may increase sleepiness and central nervous system depression.
- Methadone
- Both methadone and Lucemyra can affect your heart. Heart monitoring may be recommended when they are used together.
- Oral naltrexone
- Taking oral naltrexone close to a Lucemyra dose may reduce the effectiveness of oral naltrexone. This interaction is not expected with non-oral forms of naltrexone like Vivitrol, but a medical provider should still evaluate as needed.
- Medications that lower blood pressure or heart rate
- Combining them with Lucemyra may increase the risk of excessively low blood pressure or a slow heart rate.
Lucemyra Versus Clonidine
Lucemyra and clonidine are both alpha-2 adrenergic agonists that can reduce the nervous system overactivity associated with opioid withdrawal.The main difference is FDA approval: Lucemyra is specifically approved to help manage opioid withdrawal symptoms, while clonidine is approved for other conditions and is used off-label for opioid withdrawal. The American Society of Addiction Medicine reports that the two medications appear similarly effective, although low blood pressure may occur less often with lofexidine. Lucemyra can still cause clinically significant low blood pressure and requires medical oversight.
Is Lucemyra the Same as Suboxone?
No. Lucemyra and Suboxone serve different purposes.Lucemyra is a non-opioid medication used for short-term relief of certain withdrawal symptoms. Suboxone contains buprenorphine, an opioid medication, and naloxone. It is FDA-approved to treat opioid use disorder and may be prescribed as ongoing maintenance treatment.
One option isn't automatically better for everyone. Some people are ready to become opioid-free. For others, remaining on Suboxone or another medication for opioid use disorder may be the safer and more effective choice. The appropriate approach depends on each individual’s treatment goals, the opioids being used, medical history, previous treatment experiences, relapse and overdose risk, stability, and personal preference.
Is Lucemyra the Same as Naloxone or Naltrexone?
No, these medications work differently from one another:- Lucemyra (lofexidine) helps reduce certain opioid withdrawal symptoms.
- Naloxone, also referred to as Narcan, rapidly reverses an opioid overdose and can save a life in an emergency.
- Naltrexone blocks the effects of opioids and may help with relapse prevention after a person has completed withdrawal and is fully opioid-free.
- Vivitrol is a long-acting, injectable form of naltrexone that blocks the effects of opioids and helps prevent relapse after detox is complete and the person is fully opioid-free.
The Coleman Institute & Lucemyra
At The Coleman Institute, we've used Lucemyra in some of our past medical detoxes. However, based on our providers' clinical experience, it did not provide the same level of symptom relief as other comfort medications in our treatment protocols.Our providers found that our existing rotation of non-addictive medications was generally more effective at helping patients manage withdrawal symptoms. For this reason, we don't routinely rely on Lucemyra. Instead, we customize our detox protocols using medications selected according to each patient's individual needs.
That doesn't mean Lucemyra has no place in opioid withdrawal treatment. It is FDA-approved, and some patients and providers may find it helpful. Every person responds differently to different forms of treatment, and a medication that isn't the best fit for one detox protocol may still be appropriate for another.
Is There a Faster Alternative to Inpatient Opioid Detox?
For many people considering Lucemyra, convenience and flexibility may be considered as pros. Taking 30 days or more away from work, family, and everyday responsibilities to attend an inpatient or residential treatment program may not be realistic. While these programs provide valuable care beyond detox, not everyone requires an extended residential stay to manage opioid withdrawal safely.The Coleman Institute for Addiction Medicine offers an accelerated outpatient opioid detox program that allows eligible patients to complete detox in as little as three days. Our approach uses a personalized combination of non-addictive comfort medications and micro-doses of naltrexone to help patients manage withdrawal without general anesthesia or an extended stay in a residential facility.
Treatment is tailored to the specific substances involved, level of dependence, medical history, withdrawal risk, previous treatment experiences, and recovery goals. Before scheduling treatment, our medical team carefully screens each patient to determine whether outpatient detox is appropriate. Patients also need a trusted support person, such as a family member or friend, to assist them throughout the process.
Addiction treatment isn’t one-size-fits-all; accelerated outpatient detox isn't the right fit for everyone. Some patients may require inpatient care, while others may benefit more from transitioning to Suboxone, methadone, or another evidence-based medication. We help find a treatment approach that supports their individual needs, safety, and long-term recovery.
Take the Next Step & Embrace Sobriety
Lucemyra can help reduce some of the physical distress of opioid withdrawal, but medication management is only one part of a safe and effective detox plan. Medical supervision, personalized comfort care, relapse prevention, and aftercare all matter.If you are considering Lucemyra because you want to stop using opioids, The Coleman Institute may offer exactly what you need.
Contact The Coleman Institute at 877-773-3869 to speak with a compassionate recovery expert. Our team can answer your questions, explain our clinical approach, and help determine whether accelerated outpatient detox may be appropriate for you.
This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Do not begin, change, or stop any medication without guidance from a qualified healthcare provider.
